Clinical trial Papaldo
A phase II randomized study to verify the Papaldo hypothesis : the effectiveness of a reduced dosing of G-CSF in chemotherapy treated patients with a low to moderate risk of febrile neutropenia
| Kankers | |
|---|---|
| Organ | Borst |
| Trial status | Trial gesloten voor rekrutering |
| Investigator(s) | |
| Trial type |
Interventionneel zonder experimenteel geneesmiddel
|
| Fase | Fase van de proef 2 |
| Academisch proef | Ja |
| Sponsor | Institut Jules Bordet |
| BECT Identifier | B079201110979 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT01658956 |
| Laatste update |